Picton Mahoney Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.79M Buy
575,000
+574,945
+1,045,355% +$6.88M 0.06% 289
2026
Q1
$329 Hold
55
﹤0.01% 1234
2025
Q4
$394 Hold
55
﹤0.01% 1192
2025
Q3
$1K Hold
55
﹤0.01% 987
2025
Q2
$1K Sell
55
-1,319
-96% -$13.6K ﹤0.01% 875
2025
Q1
$21K Buy
1,374
+1,319
+2,398% +$20.3K ﹤0.01% 577
2024
Q4
$1K Hold
55
﹤0.01% 757
2024
Q3
$1K Buy
+55
New +$1.14K ﹤0.01% 744

Other funds holding OGN

Picton Mahoney Asset Management's OGN Position: Q2 2026 in Review

Picton Mahoney Asset Management increased its Organon & Co (OGN) stake by 1,045,355% in Q2 2026, buying an estimated $6.88M and bringing the position to 575,000 shares worth $7.79M. The position accounts for 0.06% of the portfolio, ranked #289.

Picton Mahoney Asset Management first reported a position in OGN in Q3 2024 and has held it in 8 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Picton Mahoney Asset Management held 575,000 shares of Organon & Co worth $7.79M as of Q2 2026.
  • Picton Mahoney Asset Management bought 574,945 Organon & Co shares in Q2 2026, an estimated $6.88M.
  • Organon & Co made up 0.06% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #289 holding.
  • Picton Mahoney Asset Management first reported a position in Organon & Co in Q3 2024 and has held it in 8 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.